“…As shown in Table 1, four studies [9,11,50,64] analysed MCI prevalence for multiple countries. The majority of studies have been conducted in China (n=55 studies [9, 11, 20, 24, 26-45, 48, 51, 52, 54, 56-58, 62, 66-68, 72-84, 86, 87, 89, 90, 94-96]), followed by India (n=6 studies [9,11,25,85,91,92]), Mexico (n=4 studies [9,11,22,65]), Brazil (n=2 studies [59,60]), Malaysia (n=2 studies [47,53]), the Philippines (n=2 studies [61,69]), Central African Republic (n=2 studies [50,64]), South Africa (n=2 studies [11,93]), Republic of Congo (n=2 studies [50,64]), and one each in Colombia [21], Nigeria [23], Cuba [9], Dominican Republic [9], Peru [9], Venezuela [9], Georgia [46], Kazakhstan [55], Tanzania [49], Bulgaria [88], Ghana [11], Russia [11], Egypt [70] and Benin West-Africa [63].…”